CADL

Candel Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

22.2%

Short % Float

10.4d to cover · High squeeze

66.8%

Inst % Float

10 holders · 2026-06-30

FMR, LLC

Top Holder

14.4% of float

56.9M sh

Public Float

27/100

Dilution Score

Medium

51 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

27/100

MEDIUM

Inst: 66.8% · Top: FMR, LLC

Biotech Analytics

Biotech / Pharma

53.74

Squeeze risk: HIGH

Insider Buying0

Publications100

Dilution Risk27

Clinical Trials92

Short Interest70